Concepedia

Dimin Wu

DW

Statistics

Publications

6

Citations

162

H-Index

6

Active since

2023

Affiliations

University of Michigan(Current)

SK Life Science (United States)

Dimin Wu is an author at University of Michigan specializing in oncology, drug discovery, and cancer pharmacology.

Publications per year

2023–2024

6

Publications

6

Discovery of <b>ERD-3111</b> as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity

Zhixiang Chen, Biao Hu, Rohan Kalyan Rej et al. · Journal of Medicinal Chemistry · 2023 · 37 citations · Full text

, , +11

Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer

Zhixiang Chen, Mi Wang, Dimin Wu et al. · Journal of Medicinal Chemistry · 2024 · 35 citations · Full text

, , +15

Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression

Zhixiang Chen, Mi Wang, Dimin Wu et al. · Journal of Medicinal Chemistry · 2024 · 32 citations · Full text

, , +16

Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression

Renqi Xu, Haibin Zhou, Longchuan Bai et al. · Journal of Medicinal Chemistry · 2024 · 22 citations · Full text

, , +8

Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα)

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen et al. · Journal of Medicinal Chemistry · 2024 · 20 citations · Full text

, , +14

1–5 of 6